Your browser doesn't support javascript.
loading
Enrollment of older metastatic breast cancer patients in first-line clinical trials: 9-year experience of the large-scale real-life multicenter French ESME cohort.
Bringuier, M; Carton, M; Levy, C; Patsouris, A; Pasquier, D; Debled, M; Rigal, O; Jacot, W; Gonçalves, A; Desmoulins, I; De La Motte Rouge, T; Bachelot, T; Ferrero, J-M; Eymard, J-C; Ung, M; Mouret-Reynier, M-A; Petit, T; Chevrot, M; Uwer, L; Courtinard, C; Frenel, J-S; Vianzone, A; Baldini, C.
Affiliation
  • Bringuier M; Department of Medical Oncoly and Department of Supportive Care, Institut Curie, PSL Research University, Saint-Cloud, France. michael.bringuier@curie.fr.
  • Carton M; Department of Biostatistics, Institut Curie, PSL Research University, Saint-Cloud, France.
  • Levy C; Department of Medical Oncology, Centre François Baclesse, Caen, France.
  • Patsouris A; Department of Medical Oncology, Institut de Cancérologie de l'Ouest - Paul Papin, Angers, France.
  • Pasquier D; Academic Department of Radiation Oncology Centre O. Lambret, CRIStAL, Lille University, Lille, France.
  • Debled M; Department of Medical Oncology, Institut Bergonie, Bordeaux, France.
  • Rigal O; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France.
  • Jacot W; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France.
  • Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
  • Desmoulins I; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • De La Motte Rouge T; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France.
  • Bachelot T; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Ferrero JM; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.
  • Eymard JC; Department of Medical Oncology, Institut de Cancérologie Jean-Godinot, Reims, France.
  • Ung M; Department of Medical Oncology, Institut Claudius Regaud - IUCT Oncopole, Toulouse, France.
  • Mouret-Reynier MA; Department of Medical Oncology, Centre Jean Perrin, Clermont Ferrand, France.
  • Petit T; Department of Medical Oncology, Centre Paul Strauss, Strasbourg, France.
  • Chevrot M; Department of Research and Development, R&D Unicancer, Paris, France.
  • Uwer L; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Nancy, France.
  • Courtinard C; Department of Research and Development, R&D Unicancer, Paris, France.
  • Frenel JS; Department of Medical Oncology, Institut de Cancérologie de l'Ouest - René Gauducheau, Nantes, France.
  • Vianzone A; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif, France.
  • Baldini C; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif, France.
Breast Cancer Res Treat ; 191(3): 577-587, 2022 Feb.
Article de En | MEDLINE | ID: mdl-34984582
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Seconde tumeur primitive Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans Langue: En Journal: Breast Cancer Res Treat Année: 2022 Type de document: Article Pays d'affiliation: France Pays de publication: Pays-Bas
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Seconde tumeur primitive Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans Langue: En Journal: Breast Cancer Res Treat Année: 2022 Type de document: Article Pays d'affiliation: France Pays de publication: Pays-Bas